Skip to main content
. 2025 Aug 15;13(8):867. doi: 10.3390/vaccines13080867
aa Amino acid
ACE2 Angiotensin-converting enzyme 2
CI Confidence interval
CXCL-10 C-X-C motif chemokine ligand 10
ECLIA Electrochemiluminescence immunoassay
IFN Interferon
NAbs Neutralizing antibodies
N-antibody Nucleocapsid-antibody
N-sero-negative Nucleocapsid-seronegative
NTD N-terminal domain
RBD Receptor-binding domain
RT-qPCR Quantitative reverse transcription PCR
S- Spike-
TP Timepoint
VOC Variant of concern